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After adjusting for age, ejection fraction and prior MI, the combination of
IVCD and antiarrhythmic drug remains a significant predictor of increased
mortality (hazard ratio 1.69, P ~ 0.04).
Conclusion Antiarrhythmic drug use is associated with and possibly a
cause of increased mortality and arrhythmic deaths in patients with an IVCD.
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simultaneously. Following imaging, the slices were fixed in formaldehyde
then stored at 4'C in 30% sucrose/phosphate buffer until processing for im-
munohistochemistry.
All of the hearts showed homogeneous thallium perfusion, however there
was evidence of a regional decrease in MIBG uptake ranging from 10% to
45% of the left ventricle, consistent with regional denervation. The defects
were generally localized to the anterior and septal territories. Immunocy-
tochemial studies on sections from regions with decreased MIBG uptake
showed a striking paucity of nerves compared to regions with normal MIBG
uptake, confirming denelVation. While all of the hearts showed denelVation,
2/3 with severe arrhythmia showed either extensive denervation or a steep
gradient in MIBG uptake, while 1/4 of the mildly affected or dogs without
arrhythmias showed extensive denervation.
We conclude that there is abnormal heterogeneous sympathetic innerva-
tion in this population of dogs with spontaneous naturally occurring ven-
tricular arrhythmias and increased incidence of sudden cardiac death. This
heterogeneity of innervation may playa role in the etiology of ventricular
arrhythmia, particularly during states of increased sympathetic tone,
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Conclusion. The negative dromotropic effect of VS, VS during SS and ISO
is attenuated by L-NMMA and restored toward baseline by L-arginine, sug-
gesting that NO plays a partial role at both prejunctional and postjunctional
sites in the vagal modulation of AV nodal conduction.
Arif Elvan, Harald P. Pride, Douglas P. Zipes. lVannertlnstitute of Cardiology,
Indianapolis, IN
Introduction. Nitric oxide (NO), synthesized from L-arginine, is involved in the
modulation of autonomic neurotransmission. Recent in vitro and in vivo stud-
ies have shown that the negative chronotropic effect of carbachol or vagal
stimulation was partially blocked by an L-arginine analog, NG-monomethyl-
L-arginine (L-NMMA), that competetively inhibits NO synthase (NOS). The
purpose of the present study was to assess in an open chest canine model
whether the L-arginine-NO pathway may also playa role in the autonomic
modulation of AV nodal conduction, and if so, whether this is prejunctional
or postjunctional.
Methods and Results. To test for prejunctional actions, we assessed the
dromotropic response to cervical vagal stimulation (VS: 2 Hz, 4.0 V. 4 ms)
and VS during ansae subclaviae stimulation (SS: 2 Hz, 3.0 V. 4 ms, n = 5).
To test for postjunctional actions, we determined the dromotropic response
to intravenous isoproterenol infusion (5 mcg/min) before and during vagal
stimulation (VS + ISO, n = 5). VS, SS and ISO were repeated during selec-
tive infusion of L-NMMA retrogradely into the AV node artery (AVNA) and
following reversal of NOS inhibition with L-arginine (100 mg/kg). Shown is
the change in AV nodal conduction time (AH, msec) produced by VS before
and during SS or isoproterenol at control state (saline infusion into AVNA, 1
ml!min), during L-NMMA infusion (4 mg/min) into AVNA, and after IV injection
of L-arginine (100 mg/kg).
*p < 0.01 vs baseline, t p < 0.01 vs L-NMMA
Role of Nitric Oxide in the Autonomic Modulation
of Atrioventricular Nodal Conduction in Dogs
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Background: Torsade de pointes (TDP) is thought to result from early af-
terdepolarizations (EADs). Although it has been shown that adenosine can
suppress catecholamine-induced EADs in isolated guinea pig ventricular my-
ocytes, its effects on TDP in vivo are uncertain.
Methods: TDP was induced in 25 anesthetized rabbits weighing 3-4 kg
by simultaneous intravenous infusion of methoxamine, an <'1-adrenoceptor
agonist (70 nmol/kg/minl, and clofilium, a blocker of the delayed rectifier K+
channel (76 nmol/kg/minl. AfterTDP was initiated, saline (n = 6) orthe adeno-
sine Al receptor agonist R-phenylisopropyladenosine (R-PIA, 1.3 mg/kg, n =
61 was infused. Two additional groups were pretreated with propranolol (2
/-Lmol/kg, n = 7), a ,Il-adrenoceptor blocker, or glibenclamide (10 /-Lmol/kg, n
= 6). an ATP sensitive K+ channel (IK-ATP) blocker. prior to R-PIA infusion.
Results:
Suppression of TOP
Adenosine Al Receptor Activation Suppresses
Torsade De Pointes by Opening ATP Sensitive K+
Channels in Rabbits
Hanno L. Tan. Charles J,y' Hou, Eric Adler, Ruey J, Sung. Stanford University Medical
Center. Stanford, CA
Suppression of TDP in the R-PIA and the R-PIA/propranolol groups was not
associated with shortening of the OT interval (baseline: 205 ± 9 ms, onset of
TDP: 344 ± 10 ms, after suppression of TDP: 400 ± 40 ms [p < NS vs onset
of TDP). mean ± SD). but with reduction of OT interval dispersion (2.7 ±
0,5%,7,5 ± 1,1 %, and 4.2 ± 0,7% [p < 0.05 vs onset of TDP], respectively).
as measured from 6 limb leads.
Conclusion: Adenosine A, receptor activation suppresses TDP induced
by K+ channel blockade primarily by opening IK-ATP, rather than byantago-
nizing ,Il-adrenoceptor mediated mechanisms. This effect is associated with
reduced OT interval dispersion, but not with OT interval shortening.
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Heterogeneous Sympathetic Innervation in
German Shepherd Dogs with Inherited Ventricular
Arrhythmia and Sudden Death
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Michael Dae, Philip Ursell, Randall Lee, Carole Stilson, Michael Chin, N.
Sydney Moise. University of California atSan Francisco; College of Veterinary
Medicine, Cornell University, Ithaca, NY
An inbred colony of German Shepherd dogs with spontaneous ventricular ar-
rhythmias and sudden death has recently been identified. The median age of
onset of the arrhythmia (4.5 months), the tendency for sudden death to occur
during REM sleep, duringffollowing exercise, and the absence of structural
heart disease suggest a developmental abnormality of the autonomic inner-
vation to the heart. To further evaluate this possibility, we studied 7 dogs from
this colony, mean age 5.2 months. Three of seven were severely affected
(frequent VT on holter). two were mildly affected, and two had no arrhyth-
mias by holter analysis. We imaged the distribution of functional myocardial
sympathetic innervation and perfusion using 1-123 metaiodobenzylguanidine
(MIBG) and thallium-201 respectively. Sympathetic nerve distribution was
evaluated morphologically by immunocytochemical localization of tyrosine
hydroxylase. Six mCi of 1-123 M IBG was injected IV followed three hours later
by 2 mCi of thallium-201. The hearts were excised, sliced transversely, and
imaged directly for MIBG and thallium. Color functional maps were derived
to display the distribution of innervation (MIBG) and perfusion (thallium-2011
Kurt C. Fabrick, Murray A. Mittleman, Joel Tsevat, Paula A. Goldman, Larry
W. Williams, Lee Goldman, Milton C. Weinstein, Brigham and Women's Hospital,
Harvard Medical School and the Harvard School ofPublic Health. Boston, MA
Two recent epidemiologic studies reported that subjects taking vitamin E(vit
E) supplements had about a 40% reduction in major coronary heart disease
(CHD) events compared with those in the lowest quintile of Vit E intake. The
Coronary Heart Disease Policy Model (CHDPM). a comprehensive computer
simulation of the costs and consequences of CHD in the US, was used to
analyze the cost-effectiveness of vit E.
The CHDPM uses age- and gender-specific distributions of CHD risk fac-
tors and age-, gender-, and risk factor-specific probabilities of disease onset
to estimate CHD and non-CHD death and morbidity. The CHDPM simulation
estimated the incremental cost-effectiveness (C/E) and the potential years of
life saved for primary (1 ') and secondary (2') prevention over 5 and 10 years.
The cost of therapy with vit E (200 IU/day) was set at $56.07/year.
For 2' prevention assuming the full efficacy observed in epidemiologic
studies, vit E saves both years of life and costs because of CHD averted,
Even at 1I8th efficacy (Men RR = 0.97, Women RR = 0,95). the incremental
C/E was $9,400 per year of life saved (YOLS) for men and $2,200 for women.
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In contrast for 10 prevention with full efficacy over 10 years, the incremental
C/E is $33,500 per YOLS for men and $35,500 for women. With the full ben-
efit suggested by the epidemiologic studies, the potential years of life saved
in the US from treatment with vit E are:
NoCP
IND N-IND
473 169 642
130 203 333
603 372 975
x2 ~ 110, P < 00001
Centrai Hemodynamic and Gas Exchange
Adaptions to Training in Chronic Heart Failure
IND N-IND
All Patients
649 369 1018
269 615 884
918 984 1902
x2 = 209, P< 00001
The Cost and Appropriateness of Radionucllde
Exercise Stress Testing by Cardiologists and
Non-cardiologists
James H. Stein, Eugene F. Uretz, Joseph E. Parrillo, John 1. Barron. Rush Medical
Co/lege, Chicago. IL
CARD
N-CARD
It is generally accepted that a patient with a normal baseline electrocardio-
gram (ECG) should undergo exercise stress testing (EST) to establish the
diagnosis and prognosis of coronary artery disease (CAD), unless standard
EST exclusion criteria are present. Initial evaluation with radionuclide EST
(REST) is an unproven approach that is approximately three times more ex-
pensive than EST alone. The appropriateness and financial ramifications of
REST at an urban university hospital were evaluated during a fourteen month
period.
Patients with clear indications for REST - previously positive EST, prior
myocardial infarction, or previous percutaneous transluminal coronary angio-
plasty - were excluded. REST studies were performed for the diagnosis or
management of CAD in 1902 patients, of whom 975 did not have chest pain.
If the baseline ECG was normal and standard EST exclusion criteria (mitral
valve prolapse, bundle-branch block, significant ST-segment deviation) were
not present, REST was considered not indicated (N-INDI.
EXERCISE PHYSIOLOGY AND TESTING
Non-eardiologists (N-CARD) were more likely than cardiologists (CARD) to
order REST studies in patients without indications for isotopes. Assuming an
excess charge of $11 00 per patient, an unnecessary $1,082,400 was billed in
this population, $409.200 of which was for patients who did not have chest
pain. Assuming a charge of $175 per patient, referral to a cardiologist prior
to REST would have saved $185,260 in this population.
In conclusion, non-cardiologists are more likely to inappropriately order
REST studies than are cardiologists, at a significant excess cost. Although
cardiologists also over utilize REST studies, referral to a cardiologist prior to
testing for CAD may be cost-effective.
treadmill testing (all of which were normal); systolic BP > 170 or diastolic
BP > 110 (n = 5). carotid bruit In = 21, severe AI by exam (n = 1). WPW (n
= 6). PVC's (n = 5). RBBB (n = 4), SVT (n = 1). EKG alone led to disqualifi-
cation in 16 or 1/350 HSA undergoing screening. No cases of hypertrophic
cardiomyopathy or anomalous coronary artery were detected prospectively.
One SCD occurred in an approved HSA due to anomalous coronary artery.
Conclusions: Common causes of SCD in HSA are rare and/or methods to
detect them are insensitive; serious CU abnormalities in this population are
rare; EKG added to the cardiovascular history and physical exam increases
the ability to detect potentially serious abnormalities necessitating further
cardiovascular testing before approval for competitive sports.
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Paul Dubach, Jonathan Myers, Gerald Dziekan, Peter Buser, Walter Reinhardt,
Reto Ratti, Thiery Carrel, Kantonsspitaler Chur. Basel, Zurich, Switzerland; Palo Afto
DVAMC. Palo Alto. CA; Stanford University, Stanford, CA
Background. Exercise Training has just recently been recognized as an impor-
tant therapeutic modality in patients with chronic heart failure (CHF). How-
ever, central hemodynamic adaptations to exercise training in patients with
CHF remain unclear.
Methods. Seventeen patients with first diagnosis of CHF (56 ± 5 years,
mean EF ~ 32 ± 6%) were randomized to an exercise raining group (N =
8), or a control group (N = 9). Patients in the exercise group performed two
hours of daily walking along with five sessions per week of high intensity
monitored stationary cycling (40 minutes at 70 to 80% peak capacity) at
a residential rehabilitation center for a period of two months. Control pa-
tients received usual community care. Ventilatory gas exchange and upright
hemodynamic measurements (rest and peak exercise cardiac output, pul-
monary artery, wedge, and mean arterial pressures, and systemic vascular
resistance) were performed before and after the study period.
Results. Changes in oxygen uptake at maximal exercise and the lactate
threshold (LT) were as follows:
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Group Follow-up Actuarial Survival (%)
(months) 5 yrs 10 yrs 15 yrs
LBBB 112 110 ± 67 96 88 81
LBBB Control 112 125 ± 69 99 92 92
RBBB 198 113 ± 71 98 95 90
RBBB Control 198 119 ± 72 99 94 90
The Natural History of Isolated Bundle Branch
Block: Results from a Population Screened Over
a Quarter Century
Gerard J. Fahy, Sergio L. Pinski, Dave P. Miller, Noeleen McCabe, Carol Pye,
Michael J. Walsh, Killian Robinson. The Irish Heart Foundation, DUblin, Ireland; The
Cleveland Clinic Foundation. Cleveland, Ohio
Prospective Screening of 5615 High School
Athletes for Sudden Cardiac Death
Colin M. Fuller, Donald A. Spring, Kosta M. Arger, Stephen A. Bruce, Eric
M. Drummer, Frank P. Kelley, Michael J. Newmark, Gerald H. Whipple. Sierra Heart
Institute and the University ofNevada Medical School, Reno, Nevada
Screening for common causes (hypertrophic cardiomyopathy and anoma-
lous coronary artery) of sudden cardiac death (SCD) in high school athletes
(HSA) during pre-participation exams is varied and relatively unstudied. Ef-
forts to improve diagnoses of potentially serious or lethal congenital heart
conditions are needed. We prospectively evaluated HSA at 34 different high
schools over three years. Cardiovascular screening included obtaining a his-
tory of angina or anginal equivalents, or a family history of SCD before age 35
years. A 12-lead EKG and a cardiovascular physical exam were performed.
Abnormalities resulted in a cardiac ultrasound (CU). Abnormal EKG for LVH
was defined in boys as SVl and RV5 > 50 mm and in girls as SVl plus RV5 >
40 mm. Follow-up of cardiovascular abnormalities followed 16th Bethesda
Conference Guidelines. Results: 5.615 HSA (3378 boys, 2237 girls) were eval-
uated. 115 (2%) had abnormal cardiovascular history, 196 (3.5%) had abnor-
mal cardiovascular exam, 193 (3.5%) had abnormal EKG and 126 (2%) had
combined abnormalities. All 630 (11 %) with abnormal cardiovascular screen-
ing underwent CU at the time of their exam. 43 HSA (7% of CU performed)
were found to have minor abnormalities. No serious previously undetected
abnormality was noted with CU. No LVH was seen in 28 HSA with LVH by
ECG. 5140 (91.5%) HSA were approved for competitive sports; 435 (7.8%1
HSA were approved for competitive sports after follow-up by local M.D. (rec-
ommended primarily for evaluation of mild hypertension); 40 (0.7%) HSA
were not approved due to anginal symptoms (n = 16) requiring subsequent
Background and Methods. The prognostic implications of the incidental dis-
covery of LBBB or RBBB in people without clinically apparent heart disease
remain uncertain. We compared the outcome of 310 such people identified
during screening carried out by The Irish Heart Foundation between 1968
and 1993, and 310 similarly screened age- and sex-matched controls with
similar cardiovascular risk factor profiles.
Results. Persons with isolated LBBB and RBBB constituted 0.1 % and
0.18% respectively, of the screened population After similar follow-up peri-
ods, total actuarial survival (Kaplan-Meier method) was no different for those
with RBBB, LBBB and their respective controls (see table).
Cardiac mortality, however, was increased in the LBBB, but not RBBB,
group when compared to their respective controls (p = 0.01, log-rank test).
At follow-up, overt cardiac disease was evident in 21 % of those with LBBB
compared to 11 % of their controls (p = 0.04). No such difference was ob-
served for those with RBBB.
Conclusions. 1. Isolated LBBB, but not RBBB is associated with an in-
creased long-term cardiac, but not total mortality. 2. Isolated LBBB is a
marker for the subsequent development of clinically overt cardiac disease.
This analysis suggests: 1) For 20 prevention, vit E is worthwhile even if it
causes a 5% or less reduction in CHD. 2) At the above cost over 10 years,
widespread 10 prevention with vit E would be cost-effective only if Vit E is
about as effective as suggested by the cohort studies. 3) If vit E is as effective
as suggested by the above studies (or even 1/8th that for 2' prevention).
then the potential loss of benefit by delaying its use is sufficiently large that
research into the efficacy of Vit E should be a high priority.
1901-671
1901-68\
